featured
FDA Approves First Treatment for Acid Sphingomyelinase Deficiency
The enzyme replacement therapy is administered through an intravenous infusion and approved for both adult and pediatric patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.